NCT02698267View on ClinicalTrials.gov

Effect of Itraconazole on the Pharmacokinetics of BIIB074

PHASE1CompletedINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

February 29, 2016

Primary Completion Date

April 30, 2016

Study Completion Date

April 30, 2016

Conditions
Neuropathic Pain
Interventions
DRUG

BIIB074

Administered as specified in the treatment arm

DRUG

Itraconazole

200 mg twice daily \[BID\] on Day 8 and once daily (QD) from Day 9 to Day 15 inclusive

Trial Locations (1)

LS2 9LH

Research Site, Leeds

Sponsors

Lead Sponsor

Biogen
All Listed Sponsors
lead

Biogen

INDUSTRY

NCT02698267 - Effect of Itraconazole on the Pharmacokinetics of BIIB074 | Biotech Hunter | Biotech Hunter